Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Orion Market Research | PRODUCT CODE: 1159426

Cover Image

PUBLISHER: Orion Market Research | PRODUCT CODE: 1159426

Kidney and Pancreas Transplant Market 2022-2028

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4000
Printable PDF & Excel (Corporate License)
USD 6625

Add to Cart

Global Kidney and Pancreas Transplant Market Size, Share & Trends Analysis Report by Sources (Living Donors, and Deceased Donors) by Treatment ((Analgesic, Immunosuppressant, and Others) by End User (Hospitals, Transplant Centers, and Others) Forecast 2022-2028

The global kidney and pancreas transplant market is anticipated to grow at a significant CAGR of 9.7% during the forecast period (2021-2028). The prominent factor that fueled the growth of the market is the higher consumption of salts in food; they blocked the pores of the kidney which causes a severe problem during filtration. Moreover, rising consumption of alcohol, hereditary conditions, trauma, medications, infections, and high lipid levels in the body, results in pancreatic disease. According to, Global Health Now in 2018-2019, the state Government of India earned collective revenue of $19.8 billion from the sale of alcohol. Maharashtra reported sales worth $8.2 million from selling 1.6 million liters of alcohol, and Uttar Pradesh, sold liquor worth, $13.2 million. The surge in the consumption of salts, alcohol, and the increasing prevalence of pancreatic diseases, fueled the growth of the global kidney and pancreas transplant market. `

Moreover, the high cost of treatment, and the risk of minor infections such as urinary tract infections (UTIs), is restraining the growth of the market. The key market players are opting for different strategies, and ways to stay competitive in the global market. For instance, in March 2022, Fresenius Medical Care announced a binding agreement with InterWell Health and Cricket Health. The merger brings together Fresenius Health Partners' expertise in kidney care value and broadens their offer by adding significant value to patients with chronic kidney diseases all over the US.

The global kidney and pancreas transplant market is segmented on the basis of sources, treatment, and end user. Based on sources, the market is sub-divided into living donors, deceased donors. Based on treatment, the market is bifurcated into analgesic, immunosuppressant, others. Based on end user, the market is sub-segmented into hospitals, transplant centers, others. Based on treatment, the analgesic segment is anticipated to grow at the highest CAGR during the forecast period. The growth is primarily driven by an increase in the incidence of chronic diseases, such as tuberculosis (TB), cancer, and arthritis. In addition, with a substantial rise in the number of patients due to infectious diseases such as gastrointestinal, respiratory, and neurology, an analgesic is used as a pain killer, hence rises in the number of chronic diseases, is expected to further drive the analgesic market share in coming future.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The European region is anticipated to grow at the fastest rate, owing to a rise in deceased donors and a higher prevalence of kidney-related diseases in the region. For instance, according to European Union, a total of 21,227 (19.9 % from living donors), organs were transplanted in 2018 from 28 EU countries, and 745 were transplanted for the pancreas. Moreover, in 2018, the number of actual deceased donors ranged from 48.3 per million people in Spain, 40.2 per million in Croatia, and 33.4 per million in Portugal. Hence, the rise in the number of deceased donors in various European regions contributes to the growth of the market during the forecast period.

The major companies serving the global kidney and pancreas transplant market are AbbVie Inc, Medtronic plc, Novartis AG, Pfizer Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Luminex, Organ Recovery Systems Inc., and Organogenesis and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaboration, funding, and new product launches, to stay competitive in the market. For instance, in March 2021, Strive Health announced that the company secured a $140million Series B round of funding led by CapitalG, Alphabet's independent growth fund. The financing supports the growing demand for strive's innovative whole-patient solutions for kidney disease populations. Moreover, strive's model with advanced technology, along with high-touch patient care slows kidney disease progression, prevents unnecessary and costly hospitalization, and expands access to optimal renal replacement therapies such as home dialysis, and transplants.

Research Methodology

The market study of the global kidney and pancreas transplant market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Kidney and Pancreas Transplant Market Research And Analysis by Sources

2. Global Kidney and Pancreas Transplant Market Research And Analysis by Treatment

3. Global Kidney and Pancreas Transplant Market Research And Analysis by End User

The Report Covers:

  • Comprehensive Research Methodology of the global kidney and pancreas transplant market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global kidney and pancreas transplant market.
  • Insights about market determinants that are stimulating the global kidney and pancreas transplant market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Product Code: OMR2026597

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Kidney and Pancreas Transplant Market
  • Recovery Scenario Of Global Kidney and Pancreas Transplant Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight and Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. AbbVie Inc.
      • 3.1.1.1. Overview
      • 3.1.1.2. Financial Analysis
      • 3.1.1.3. SWOT Analysis
      • 3.1.1.4. Recent Developments
    • 3.1.2. Medtronic Plc
      • 3.1.2.1. Overview
      • 3.1.2.2. Financial Analysis
      • 3.1.2.3. SWOT Analysis
      • 3.1.2.4. Recent Developments
    • 3.1.3. Novartis AG
      • 3.1.3.1. Overview
      • 3.1.3.2. Financial Analysis
      • 3.1.3.3. SWOT Analysis
      • 3.1.3.4. Recent Developments
      • 3.1.3.5. Recent Developments
    • 3.1.4. Pfizer Inc.
      • 3.1.4.1. Overview
      • 3.1.4.2. Financial Analysis
      • 3.1.4.3. SWOT Analysis
      • 3.1.4.4. Recent Developments
      • 3.1.4.5. Recent Developments
    • 3.1.5. Thermo Fisher Scientific Inc
      • 3.1.5.1. Overview
      • 3.1.5.2. Financial Analysis
      • 3.1.5.3. SWOT Analysis
      • 3.1.5.4. Recent Developments
      • 3.1.5.5. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Kidney and Pancreas Transplant Market by Sources
    • 4.1.1. Living Donors
    • 4.1.2. Deceased Donors
  • 4.2. Global Kidney and Pancreas Transplant Market by Treatment
    • 4.2.1. Analgesic
    • 4.2.2. Immunosuppressant
    • 4.2.3. Others
  • 4.3. Global Kidney and Pancreas Transplant Market by End User
    • 4.3.1. Hospitals
    • 4.3.2. Transplant Centers
    • 4.3.3. Others

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Arthrex GmbH
  • 6.2. Bio-Rad
  • 6.3. CareDx Inc
  • 6.4. Dr. Franz Kohler Chemie GmbH
  • 6.5. F. Hoffmann-La Roche Ltd.
  • 6.6. Luminex
  • 6.7. Organ Recovery Systems Inc.
  • 6.8. Organogenesis
  • 6.9. Sanofi US
  • 6.10. Stryker
  • 6.11. Teva Pharmaceutical Industries Ltd.
  • 6.12. Veloxis Pharmaceuticals
Product Code: OMR2026597

LIST OF TABLES

  • 1. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY SOURCES, 2021-2028 ($ MILLION)
  • 2. GLOBAL LIVING DONORS AVAILABLE IN KIDNEY AND PANCREASE TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL DECEASED DONORS AVAILABLE IN KIDNEY AND PANCREASE TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
  • 5. GLOBAL ANALGESIC FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL IMMUNOSUPPRESSANT FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2021-2028 ($ MILLION)
  • 7. GLOBAL OTHER TREATMENT FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2021-2028 ($ MILLION)
  • 8. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 9. GLOBAL HOSPITALS FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2021-2028 ($ MILLION)
  • 10. GLOBAL TRASNPLANT CENTERS FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2021-2028 ($ MILLION)
  • 11. GLOBAL OTHER FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS, 2021-2028 ($ MILLION)
  • 12. NORTH AMERICAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)
  • 13. NORTH AMERICAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY SOURCES,2021-2028($ MILLION)
  • 14. NORTH AMERICAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028($ MILLION)
  • 15. NORTH AMERICAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END USER, 2021-2028($ MILLION)
  • 16. EUROPEAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)
  • 17. EUROPEAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY SOURCES,2021-2028($ MILLION)
  • 18. EUROPEAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028($ MILLION)
  • 19. EUROPEAN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END USER, 2021-2028($ MILLION)
  • 20. ASIA-PACIFIC KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)
  • 21. ASIA-PACIFIC KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY SOURCES,2021-2028($ MILLION)
  • 22. ASIA-PACIFIC KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TREATMENT,2021-2028($ MILLION)
  • 23. ASIA-PACIFIC KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END USER,2021-2028($ MILLION)
  • 24. REST OF THE WORLD KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028($ MILLION)
  • 25. REST OF THE WORLD KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY SOURCES,2021-2028($ MILLION)
  • 26. REST OF THE WORLD KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY TREATMENT,2021-2028($ MILLION)
  • 27. REST OF THE WORLD KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY END USER,2021-2028($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET, 2021-2028(%)
  • 4. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET SHARE BY SOURCES, 2021-2028(%)
  • 5. GLOBAL LIVING DONORS AVAILABLE IN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 6. GLOBAL DECEASED DONORS AVAILABLE IN KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 7. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET SHARE BY TREATMENT, 2021-2028(%)
  • 8. GLOBAL ANALGESIC FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 9. GLOBAL IMMUNOSUPPRESSANT FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 10. GLOBAL OTHERS FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 11. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET SHARE BY END USER, 2021-2028(%)
  • 12. GLOBAL HOSPITALS FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 13. GLOBAL TRANPLANT CENTERS FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 14. GLOBAL OTHERS FOR KIDNEY AND PANCREAS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 15. GLOBAL KIDNEY AND PANCREAS TRANSPLANT MARKET BY SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 16. US KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)
  • 17. CANADA KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)
  • 18. UK KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)
  • 19. GERMANY KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)
  • 20. SPAIN KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)
  • 21. FRANCE KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)
  • 22. ITALY KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)
  • 23. REST OF EUROPE KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)
  • 24. INDIA KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)
  • 25. CHINA KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)
  • 26. JAPAN KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)
  • 27. REST OF ASIA-PACIFIC KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)
  • 28. REST OF WORLD KIDNEY AND PANCREAS TRANSPLANT MARKET SIZE, 2021-2028($ MILLION)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!